FDA warns about possible SARS-CoV-2, COVID-19 transmission with FMT

The FDA issued a safety alert for the use of fecal microbiota transplantation and the possible risk for transmission of the SARS-CoV-2 virus.According to the safety alert, various studies have shown SARS-CoV RNA and the SARS-CoV-2 virus present in stools of infected patients, demonstrating that the virus may be transmitted by an FMT.The FDA noted that the clinical use of FMT, whether used in a study under an investigational new drug application on file with the FDA or under the FDA’s enforcement discretion policy, may potentially transmit the virus. Per the FDA, precautions needed forRead More

Share on facebook
Share on twitter
Share on linkedin